WithdrawnNCT01155544
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Behavioural studyAges 16–44United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 16 years to 44 years.
- Listed locations
- Glen Oaks and 1 more locationSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJune 2011
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Northwell Health
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Behavioural
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 16 Years to 44 Years
- Official registry ID
- NCT01155544
- Official title
Show the full official title
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Glen Oaks · Manhasset
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Northwell Health.
Who can participate?
Listed age limits: 16 years to 44 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
